New gene therapy duo targets hard-to-treat melanoma
Disease control
Completed
This study tested a new approach for people with advanced melanoma (stage III or IV) that cannot be removed by surgery. Participants received injections of a gene therapy directly into their tumors, plus an oral activator drug, to boost the immune system's ability to fight cancer…
Phase: PHASE1, PHASE2 • Sponsor: Alaunos Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:56 UTC